Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03518658 · ClinicalTrials.gov registry record
BlueSync Field Evaluation
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 257
- Enrollment target
NCT03518658 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 257 participants.
The verdict
NCT03518658 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
Study Summary
The purpose of this field evaluation is to collect and evaluate information related to CareLink transmission compliance as well as patient perceived benefit of BlueSync™ and the health care provider perception of the value of BlueSync™ and satisfaction with BlueSync™.
Interventions
- OTHER Evaluation Group
- OTHER Control Group (Historical)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2019-12-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03518658
The ClinicalTrials.gov registry entry for NCT03518658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Evaluation Group is the first listed.
NCT03518658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03518658 about?
NCT03518658 is a clinical study titled "BlueSync Field Evaluation". The purpose of this field evaluation is to collect and evaluate information related to CareLink transmission compliance as well as patient perceived benefit of BlueSync™ and the health care provider perception of the value of BlueSync™ and satisfaction with BlueSync™.
What is the current status of trial NCT03518658?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2018-04-02. Estimated completion is 2019-12-29.
What interventions are being tested in trial NCT03518658?
The interventions under investigation include: Evaluation Group (OTHER), Control Group (Historical) (OTHER).
Who is sponsoring clinical trial NCT03518658?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.